TRAX
First Tracks Biotherapeutics, Inc.
30.60$
-2.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | – | – | – | |
| – | -0.8% | -79.2% | +65.6% | |
| – | -1.2% | +50.2% | -27.7% | |
| – | – | – | -214.5% | |
| – | +11.4% | -56.4% | +47.1% | |
| – | – | – | -100.1% | |
| – | -1,011.6% | – | -717.9% | |
| – | – | – | -883.1% | |
| – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.